Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model.
- Published In:
- Cells, 12(12) (2023)
- Authors:
- Kim, Jieun, Lee, Chanbin, Han, Jinsol, Jeong, Hayeong, Wang, Sihyung, Choi, Yung Hyun, Jung, Youngmi
- Database ID:
- RPEP-07044
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07044APA
Kim, Jieun; Lee, Chanbin; Han, Jinsol; Jeong, Hayeong; Wang, Sihyung; Choi, Yung Hyun; Jung, Youngmi. (2023). Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model.. Cells, 12(12). https://doi.org/10.3390/cells12121658
MLA
Kim, Jieun, et al. "Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model.." Cells, 2023. https://doi.org/10.3390/cells12121658
RethinkPeptides
RethinkPeptides Research Database. "Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cel..." RPEP-07044. Retrieved from https://rethinkpeptides.com/research/kim-2023-targeted-deletion-of-thymosin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.